Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteosarcoma | 2 | 2023 | 897 | 1.110 |
Why?
|
Soft Tissue Neoplasms | 3 | 2023 | 1152 | 1.070 |
Why?
|
Fibroma | 2 | 2024 | 190 | 1.000 |
Why?
|
Fibroma, Ossifying | 1 | 2023 | 14 | 0.910 |
Why?
|
Sarcoma | 3 | 2023 | 1786 | 0.910 |
Why?
|
RNA-Binding Protein EWS | 1 | 2024 | 210 | 0.830 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2022 | 47 | 0.780 |
Why?
|
Cystadenoma, Papillary | 1 | 2021 | 9 | 0.780 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2021 | 33 | 0.780 |
Why?
|
Liposarcoma | 1 | 2024 | 283 | 0.760 |
Why?
|
Endometrial Hyperplasia | 1 | 2022 | 97 | 0.750 |
Why?
|
Bone Neoplasms | 2 | 2023 | 2532 | 0.710 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2024 | 556 | 0.700 |
Why?
|
Gene Amplification | 1 | 2024 | 1085 | 0.670 |
Why?
|
Chondrosarcoma | 1 | 2022 | 296 | 0.660 |
Why?
|
Carcinoma, Renal Cell | 4 | 2022 | 3218 | 0.650 |
Why?
|
Carcinoma, Endometrioid | 1 | 2022 | 276 | 0.640 |
Why?
|
Genital Neoplasms, Female | 1 | 2024 | 533 | 0.640 |
Why?
|
Neuroendocrine Tumors | 2 | 2022 | 650 | 0.630 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2021 | 1596 | 0.510 |
Why?
|
Leiomyosarcoma | 3 | 2023 | 424 | 0.480 |
Why?
|
Adenoma | 1 | 2023 | 2148 | 0.410 |
Why?
|
Endometrial Neoplasms | 1 | 2022 | 1357 | 0.410 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 2 | 2023 | 77 | 0.380 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1607 | 0.370 |
Why?
|
Immunohistochemistry | 6 | 2024 | 11071 | 0.370 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2023 | 2003 | 0.360 |
Why?
|
Kidney Neoplasms | 3 | 2022 | 4312 | 0.350 |
Why?
|
Biopsy | 4 | 2023 | 6771 | 0.340 |
Why?
|
Ovarian Neoplasms | 3 | 2024 | 4878 | 0.320 |
Why?
|
Pancreatic Neoplasms | 2 | 2022 | 5351 | 0.290 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6315 | 0.250 |
Why?
|
Epithelioid Cells | 1 | 2024 | 60 | 0.230 |
Why?
|
Diagnosis, Differential | 4 | 2024 | 12965 | 0.220 |
Why?
|
Polyploidy | 1 | 2024 | 119 | 0.220 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5799 | 0.220 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2024 | 100 | 0.220 |
Why?
|
Uterine Neoplasms | 2 | 2022 | 1439 | 0.220 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2023 | 151 | 0.210 |
Why?
|
Ileal Neoplasms | 1 | 2022 | 20 | 0.210 |
Why?
|
Leiomyomatosis | 1 | 2022 | 69 | 0.210 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2024 | 196 | 0.200 |
Why?
|
Placenta Previa | 1 | 2024 | 122 | 0.200 |
Why?
|
Gene Rearrangement | 2 | 2024 | 1122 | 0.200 |
Why?
|
Mitotic Index | 1 | 2022 | 161 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2024 | 368 | 0.190 |
Why?
|
5-Methylcytosine | 1 | 2022 | 146 | 0.190 |
Why?
|
Hypertension, Portal | 1 | 2023 | 226 | 0.190 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2024 | 328 | 0.190 |
Why?
|
SOX9 Transcription Factor | 1 | 2022 | 145 | 0.190 |
Why?
|
Fibromatosis, Aggressive | 1 | 2022 | 125 | 0.190 |
Why?
|
Clathrin Heavy Chains | 1 | 2020 | 27 | 0.180 |
Why?
|
Pelvic Neoplasms | 1 | 2022 | 248 | 0.180 |
Why?
|
Placenta Accreta | 1 | 2024 | 237 | 0.170 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2024 | 479 | 0.170 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2021 | 307 | 0.170 |
Why?
|
Female | 19 | 2024 | 391270 | 0.160 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2024 | 2506 | 0.150 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 317 | 0.150 |
Why?
|
Fibroblast Growth Factors | 1 | 2024 | 869 | 0.150 |
Why?
|
Leiomyoma | 1 | 2022 | 654 | 0.150 |
Why?
|
Microscopy, Electron | 1 | 2021 | 2558 | 0.150 |
Why?
|
Peritoneal Neoplasms | 1 | 2024 | 707 | 0.150 |
Why?
|
Humans | 24 | 2024 | 760621 | 0.140 |
Why?
|
Osteogenesis | 1 | 2023 | 1271 | 0.140 |
Why?
|
Ovary | 1 | 2021 | 958 | 0.140 |
Why?
|
Point Mutation | 1 | 2021 | 1594 | 0.130 |
Why?
|
Femur | 1 | 2021 | 1302 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2024 | 3616 | 0.120 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1056 | 0.120 |
Why?
|
Neoplasm Invasiveness | 1 | 2023 | 3618 | 0.120 |
Why?
|
Nephrectomy | 1 | 2020 | 1016 | 0.120 |
Why?
|
Translocation, Genetic | 1 | 2020 | 1388 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2414 | 0.120 |
Why?
|
Middle Aged | 8 | 2024 | 220352 | 0.110 |
Why?
|
Transcription Factors | 2 | 2024 | 12103 | 0.110 |
Why?
|
Kidney | 2 | 2020 | 7064 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2022 | 11152 | 0.090 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4713 | 0.090 |
Why?
|
Eye | 1 | 2013 | 710 | 0.080 |
Why?
|
Crohn Disease | 1 | 2022 | 2275 | 0.080 |
Why?
|
DNA-Binding Proteins | 2 | 2023 | 9585 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5791 | 0.080 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2013 | 739 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3758 | 0.080 |
Why?
|
Growth Hormone | 1 | 2010 | 568 | 0.080 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15289 | 0.070 |
Why?
|
Islets of Langerhans | 1 | 2013 | 1345 | 0.070 |
Why?
|
Retrospective Studies | 3 | 2024 | 80372 | 0.070 |
Why?
|
Leptin | 1 | 2013 | 1591 | 0.060 |
Why?
|
Adolescent | 2 | 2024 | 87810 | 0.060 |
Why?
|
Prognosis | 2 | 2023 | 29658 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9276 | 0.060 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2024 | 59 | 0.060 |
Why?
|
Adult | 6 | 2024 | 219994 | 0.060 |
Why?
|
Immunity | 1 | 2010 | 998 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2022 | 22053 | 0.060 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2024 | 101 | 0.060 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2023 | 72 | 0.060 |
Why?
|
Adnexal Diseases | 1 | 2024 | 106 | 0.050 |
Why?
|
Fumarate Hydratase | 1 | 2022 | 52 | 0.050 |
Why?
|
Rhabdomyosarcoma | 1 | 2024 | 359 | 0.050 |
Why?
|
Uterus | 1 | 2024 | 651 | 0.040 |
Why?
|
Ileum | 1 | 2022 | 555 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2023 | 673 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2022 | 659 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2093 | 0.040 |
Why?
|
Child | 2 | 2024 | 79806 | 0.040 |
Why?
|
Male | 4 | 2024 | 359744 | 0.040 |
Why?
|
Hysterectomy | 1 | 2024 | 904 | 0.040 |
Why?
|
Cicatrix | 1 | 2024 | 782 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 895 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1612 | 0.040 |
Why?
|
Gene Expression | 1 | 2010 | 7588 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 58741 | 0.040 |
Why?
|
Aged | 3 | 2024 | 169152 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2024 | 3775 | 0.030 |
Why?
|
Cesarean Section | 1 | 2024 | 1385 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1889 | 0.030 |
Why?
|
Placenta | 1 | 2024 | 1702 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2058 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 65017 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 2013 | 0.030 |
Why?
|
Mice, Obese | 1 | 2013 | 420 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14660 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5794 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2010 | 859 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16546 | 0.020 |
Why?
|
Cattle | 1 | 2010 | 3847 | 0.010 |
Why?
|
Down-Regulation | 1 | 2010 | 2913 | 0.010 |
Why?
|
Glycoproteins | 1 | 2010 | 2208 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 29749 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4122 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 24123 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41335 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 29932 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 58995 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2010 | 9530 | 0.010 |
Why?
|
Mice | 2 | 2013 | 81208 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9411 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 22023 | 0.010 |
Why?
|
Animals | 2 | 2013 | 167963 | 0.010 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_